This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Analysts' Actions: SIRI C ED JACK HES BBT

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Astea (ATEA) upgraded to buy at TheStreet Ratings.

Berkshire Hathaway (BRK.B) upgraded to buy at TheStreet Ratings.

BB&T (BBT - Get Report) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $34 price target. Valuation call, as the stock is up 32% year-to-date.

Ball (BLL) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Valuation call, based on a $44 price target.

Berry Petroleum (BRY) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $38 price target. Core California project has a muted growth outlook.

Citigroup (C - Get Report) upgraded at KBW from Market Perform to Outperform, Keefe, Bruyette & Woods said. $44 price target. Fundamentals should improve and the company trades at two-thirds of its tangible book value.

CBOE (CBOE) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $27 price target. Company is facing higher costs and delaying its buyback.

Consolidated Edison (ED - Get Report) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $60 price target. Company trades at a premium valuation and there are risks surrounding the company's upcoming rate case.

Fidelity National (FIS) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $35 price target. Industry faces long-term growth headwinds.

Fifth Third (FITB) downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Valuation call, as the company lacks near-term catalysts.

Healthcare Services (HCSG) downgraded at Benchmark from Buy to Hold, Benchmark said. Valuation call, based on a $23.50 price target.

Hess (HES - Get Report) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Company faces capital efficiency concerns. $60 price target.

IDEX Corporation (IEX) downgraded at Oppenheimer to Perform from Outperform, Oppenheimer said. Lower organic growth prospects.

Informatica (INFA) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $31 price target. Company will struggle to achieve 2013 earnings expectations.

Jack in the Box (JACK - Get Report) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Stock has made a big run versus its peers. $26 price target.

KB Home (KBH) downgraded at Citigroup to Sell from Neutral, Citigroup said. $12 price target. Agressive valuation considering leverage.

Knight Transportation (KNX) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $15 price target. Stock will likely lag its peers in the coming quarters.

Lennar (LEN) upgraded at Citigroup to Neutral from Sell, Citigroup said. $35 price target. Underperformed peers despite above average growth.

Liberty Media (LMCA) upgraded at Citigroup to Buy from Neutral, Citigroup said. $121 price target. Moving toward hard control of Sirius.

Microchip (MCHP) upgraded at ThinkEquity from Hold to Buy, ThinkEquity said. $38 price target. Recent acquisitions should add to earnings.

ON Semiconductor (ONNN) upgraded at ThinkEquity from Hold to Buy, ThinkEquity said. New CFO will drive to improve profitability. $8 price target.

Palo Alto (PANW) rated new Outperform at JMP. $77 price target. Company can capitalize on explosive demand for next-generation security.

PNC Financial (PNC) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $71 price target. Stock has lagged its peers for too long. $71 price target.

SAIC (SAI) downgraded at JP Morgan from Neutral to Underperform, JP Morgan said. $11 price target. Stock trades at a premium to its peers, even though the company still has to restructure.

Sirius XM (SIRI) rated new Buy at BofA/Merrill. $3.75 price target. Company can leverage its premier content and growing subscriber base.

Silgan (SLGN) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $44 price target. Stock should lag its peers in the coming quarters.

Safeway (SWY) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $15 price target. Expect the company to lag its peers in the coming quarters.

Integrys Energy (TEG) upgraded at DA Davidson from Neutral to Buy, DA Davidson said. $59 price target. Asset purchase should boost the rate base.

Tyler Technologies (TYL) rated new Buy at ThinkEquity. $50 price target. Company is a market leader and can continue to gain market share.

Valmont (VMI) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Valuation call, based on a $123 price target.

Wells Fargo (WFC) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $36 price target. Valuation call, as the stock is up 25% year-to-date.

WR Berkley (WRB) downgraded at Goldman to Sell, Goldman Sachs said. Valuation call, based on a $35 price target.

STOCK COMMENTS / EPS CHANGES

ARIAD Pharma (ARIA) target raised at Jefferies to $28, Jefferies said. Early AP26113 efficacy data encouraging. Buy rating.

Anheuser-Busch InBev (BUD) added to Key Call List at UBS. US top line momentum with margin upside. $94.06 price target.

Celanese (CE) numbers cut at UBS. Shares of CE now seen reaching $47, UBS said. Estimates also lowered on new growth guidance.

Generac (GNRC) estimates, target raised at BMO. Shares of GNRC now seen reaching $30, according to BMO Capital. Estimates also increased, given large power outages. Outperform rating.

International Paper (IP) numbers reduced at BMO. IP estimates were cut through 2013, BMO Capital said. Company is discounting more and seeing lower demand for pulp.

Kronos Worldwide (KRO) numbers lowered at Oppenheimer. Shares of KRO now seen reaching $20, Oppenheimer said. Estimates also lowered on ugly pre-announcement. Outperform rating.

Pentair (PNR) numbers raised at Oppenheimer. Shares of PNR now seen reaching $46, Oppenheimer said. Estimates also raised on merger possibilities. Perform rating.

Travelers (TRV) cut from Conviction Buy List at Goldman. Valuation call, based on a $75 price target.

STRATEGY CALLS / MARKET CALLS

MedTech sector upgraded at BMO. Medical Technology sector was upgraded from Market Perform to Outperform, BMO Capital said. End-markets are stabilizing and expectations appear reasonable. BAX, MDT, STJ and ZMH are among the analyst's top picks.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
BBT $38.05 0.00%
C $52.42 0.00%
ED $63.14 0.00%
HES $75.08 0.00%
JACK $96.69 0.00%

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs